Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)
Clinical trial NCT06931405 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06931405
- Sponsor
- Blueprint Medicines Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-28
- Primary completion
- 2026-12-31
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.